PRAME and nonpapillary renal cell carcinoma: However, a significant difference in the expressions of PSAT1, PRAME, KDELR3 was observed between groups; these genes were highly expressed in patients with late-stage ccRCC than in those with early-stage ccRCC (all p < 0.05) (Table 1).